Friday, April 24, 2009

U.S. Bans Hurt Ranbaxy's Sales

India's Ranbaxy Labs reported a net loss of $153 million for the first quarter, hurt by currency fluctuations, a U.S. ban on some of its drugs and the global slowdown.

more 

No comments:

Post a Comment